WO2020263904A1
|
|
Compositions and methods of treating or preventing ocular infections with filociclovir
|
WO2020186025A1
|
|
Combination drug treatment for human cytomegalovirus
|
WO2020185620A1
|
|
Inhibition of adenovirus with filociclovir
|
AU2018321845A1
|
|
Metabolically stable N-acylaminooxadiazoles useful as antibacterial agents
|
WO2018204322A1
|
|
Multimeric inhibitors of bacterial type iii secretion system
|
US2019292165A1
|
|
Broad spectrum inhibitors of filoviruses
|
AU2015255306A1
|
|
Inhibitors of viral entry into mammalian cells
|
CA2910593A1
|
|
Antimicrobial potentiators
|
AU2013203340A1
|
|
Inhibitors of bacterial biofilm formation
|
WO2013074965A1
|
|
Aminoalkyl phenol ether inhibitors of influenza a virus
|
WO2013052263A2
|
|
Antifungal compounds
|
WO2013040527A1
|
|
Antimicrobial compounds
|
WO2013040526A1
|
|
Antimicrobial compounds
|
WO2013040528A1
|
|
Antimicrobial compounds
|
AU2012281019A1
|
|
Inhibitors of bacterial type III secretion system
|
AU2012280936A1
|
|
Inhibitors of bacterial type III secretion system
|
CN103491956A
|
|
Inhibitors of viral entry into mammalian cells
|
WO2011022721A1
|
|
Inhibitors of botulinum neurotoxins
|
AU2010307262A1
|
|
Inhibitors of filovirus entry into host cells
|
EP2416661A1
|
|
Inhibitors of bacterial type iii secretion system
|